Amneal Pharmaceuticals, Inc. (AMRX)
14.50
-0.10
(-0.68%)
USD |
NASDAQ |
Feb 20, 16:00
14.53
+0.03
(+0.21%)
Pre-Market: 20:00
Amneal Pharmaceuticals SG&A Expense (Quarterly) : 137.82M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 123.98M |
| Pfizer Inc. | 4.162B |
| Apellis Pharmaceuticals, Inc. | 142.68M |
| Nektar Therapeutics | 16.07M |
| Innoviva, Inc. | 27.29M |